Katia Jessica Flores Aparco
KATIA FLORESKATIA FLORES

Katia Jessica Flores Aparco

SPECIALIST PHYSICIAN IN HEMATOLOGY AND HEMOTHERAPY

CV Médicos biobuilder con centros Katia Jessica Flores Aparco

Centros en los que trabaja el profesional

See more specialists on Barcelonabarcelona

en/medical-staff/hematologist

Key information

  • Latest Publication:
    Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Professional Details

Hospital Universitari General de Catalunya
SPECIALIST PHYSICIAN HAEMATOLOGY AND HAEMOTHERAPY
October 2022 - Present
Hospital Universitari Sagrat Cor
SPECIALIST PHYSICIAN HAEMATOLOGY AND HAEMOTHERAPY
October 2022 - Present
Hospital Universitari Gral. de Catalunya
University Clinical Tutor
January 2018 - January 2022
Hospital Universitari Gral. de Catalunya
Specialist doctor
January 2017 - January 2022
Study
Medical Doctor
university, Universidad Nacional Federico Villarreal
2011
Another qualification
Hematological Cytology Course
hospital
Another qualification
Specialty in Hematology and Hemotherapy
hospital
1st Hematological Cytology Workshop
Hospital Universitari General de Catalunya
January 2019 - January 2019
RIETE: Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombic
RIETE: Timing and characteristics of venous thromboembolism after noncancer surgery
RIETE: Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
RIETE: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
RIETE: Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
RIETE: Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation
Natural history of patients with venous thromboembolism and hereditary haemorrhagic telangiectasia. Findings from the RIETE registry
Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE
RIETE: Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombic
RIETE: Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
RIETE: Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
RIETE: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
RIETE: Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
RIETE: Timing and characteristics of venous thromboembolism after noncancer surgery
Make an appointment with this professional

Consulta el contenido multimedia de este profesional.

Hospitals

Book an appointment now at one of our hospitals.

Articles on

Browse the latest articles on Tu canal de salud.

No tienes seguro de saludNo tienes seguro de salud

¿No tienes seguro de salud?

Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.